Drug related morbidity and mortality updating the cost of illness

Posted by / 26-Nov-2019 12:18

Drug related morbidity and mortality updating the cost of illness

Method Setting The present study was carried out in eleven outpatient departments including respiratory, endocrine, and cardiovascular in five hospitals in the northern, central, and southern areas of Jordan.These hospitals represent major hospitals in distinctive areas of Jordan and include King Abdullah University Hospital (KAUH), a teaching hospital affiliated with the Jordan University of Science and Technology in Irbid; Jordan University Hospital, a teaching hospital affiliated with the University of Jordan in Amman; Al-Basheer Hospital, a public hospital in Amman; Princess Basma Hospital, a public hospital in Irbid; and Al-Karak Hospital, a public hospital in Al-Karak.Main outcome measure: Drugs associated with different types of TRPs.

S180747 Checked for plagiarism Yes Review by Single-blind Peer reviewers approved by Dr Amy Norman Peer reviewer comments 2 Editor who approved publication: Professor Garry Walsh School of Pharmacy and Pharmaceutical Science, University of Ulster, Coleraine, County Londonderry, UK Background: Treatment-related problems (TRPs) may pose risks for patients if unaddressed.Setting: Outpatient departments of five public and teaching hospitals in Jordan.Method: TRPs and drugs most commonly implicated with TRPs were assessed for patients recruited from outpatient clinics in five major hospitals in Jordan using a standardized and validated pharmaceutical care manual.Keywords: drug related problems, drug therapy problems, high alert medication, Jordan, pharmaceutical care, treatment related problems Introduction Treatment-related problems (TRPs) are associated with the use of medications that result in decreased therapeutic outcomes, which are usually addressed by pharmacists. TRPs can lead to decreased disease control and adverse effects.Such TRPs might lead to overutilization of health care resources, with associated high costs for the health care system, in particular for elderly patients.

drug related morbidity and mortality updating the cost of illness-86drug related morbidity and mortality updating the cost of illness-52drug related morbidity and mortality updating the cost of illness-58

In Jordan, a number of studies have been published describing typical pharmaceutical care research and the impact of clinical pharmacy interventions.

One thought on “drug related morbidity and mortality updating the cost of illness”